Elkfork Partners’s Myriad Genetics MYGN Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2019
Q3 | $373K | Buy |
13,020
+700
| +6% | +$20.1K | 0.01% | 664 |
|
|
2019
Q2 | $342K | Buy |
12,320
+532
| +5% | +$14.8K | 0.01% | 689 |
|
|
2019
Q1 | $391K | Hold |
11,788
| – | – | 0.01% | 625 |
|
|
2018
Q4 | $343K | Hold |
11,788
| – | – | 0.01% | 622 |
|
|
2018
Q3 | $542K | Buy |
11,788
+756
| +7% | +$34.8K | 0.01% | 572 |
|
|
2018
Q2 | $412K | Hold |
11,032
| – | – | 0.01% | 588 |
|
|
2018
Q1 | $326K | Buy |
11,032
+1,708
| +18% | +$50.5K | 0.01% | 648 |
|
|
2017
Q4 | $320K | Buy |
9,324
+1,512
| +19% | +$51.9K | 0.01% | 661 |
|
|
2017
Q3 | $283K | Buy |
7,812
+1,260
| +19% | +$45.6K | 0.01% | 633 |
|
|
2017
Q2 | $169K | Buy |
6,552
+2,968
| +83% | +$76.6K | 0.01% | 743 |
|
|
2017
Q1 | $69K | Buy |
+3,584
| New | +$69K | ﹤0.01% | 839 |
|